Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance. - Wikidata - awgldk - TriplyDB

Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance.

Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance.

http://www.wikidata.org/entity/Q34850830

about

Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease.Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition Effects of hormone therapy on brain structure: A randomized controlled trial.Prevalence of metabolic syndrome in pre- and postmenopausal women.Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial.

P2860

Q28547748-82877999-CA45-4091-8791-BF9BC054A054 Q35282590-AB0FD9C5-1ECF-4A82-8334-BDCBE40CCD09 Q37113841-4907F2ED-18B6-427B-BF31-B610566DBDEE Q37280188-9DB69029-E85B-497C-8DC5-292CB6615E89 Q40323684-9BB690AD-A696-4D4F-9700-0717CE55FDD1 Q55164200-58DF9078-6012-465E-98E9-9F6C17642321

P2860

Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance.

http://www.wikidata.org/entity/Q34850830

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Characterization of vascular d ...... on with cognitive performance.

@ast

Characterization of vascular d ...... on with cognitive performance.

@en

Characterization of vascular d ...... on with cognitive performance.

@nl

type

label

Characterization of vascular d ...... on with cognitive performance.

@ast

Characterization of vascular d ...... on with cognitive performance.

@en

Characterization of vascular d ...... on with cognitive performance.

@nl

prefLabel

Characterization of vascular d ...... on with cognitive performance.

@ast

Characterization of vascular d ...... on with cognitive performance.

@en

Characterization of vascular d ...... on with cognitive performance.

@nl

P1433

Q34850830-6B203D3B-6F3D-4357-A07F-024EC3E3D626

P1476

Q34850830-D084171A-4473-4F50-BCFA-45C615493116

P2093

Q34850830-037D1EC5-AA5A-47AB-A00B-1DAE340F50CA

Q34850830-25AE7867-ABA2-4E08-8C1A-9263D6BF0D8B

Q34850830-2806C6C9-4016-418B-89DF-1EE81E39FBF3

Q34850830-386ABCEC-F4BD-499B-BB57-6A8B0BB84C5F

Q34850830-4AF010C0-BC16-46A4-B963-FBDD29F2C154

Q34850830-5D0B050C-7D0A-45A5-9776-DEEB7018C397

Q34850830-6148F60A-9DBC-47C4-AE3A-3ABEEFB03234

Q34850830-8459B3FF-EC37-4F03-A45E-342D0F0B0B99

Q34850830-931EE3BF-D01D-4C7F-9273-066A6944F878

Q34850830-94BA3467-711E-42AD-BF7C-DF619980EB42

P2860

Q34850830-07371E4F-1DBC-4345-B2C3-050B3A0C1E1B

Q34850830-09F32D83-B815-4C4A-81DB-A6657913C472

Q34850830-0BEE5186-5C26-487B-B7DB-3777E0650541

Q34850830-0D6E8888-A0CE-44F4-9884-0DBD8F0064FE

Q34850830-0F2A07D5-B21E-4B40-A74B-AEC712A19328

Q34850830-15863E49-4A17-4037-BFB0-6B13E57F7DBA

Q34850830-18A364E5-5760-45C2-8BA4-6909FD4B4FE0

Q34850830-19AA6DCD-CD07-47CF-B480-FE7B879ADE09

Q34850830-1ECC3F87-CF54-4814-A383-C72D8D44DC44

Q34850830-2820BB70-0873-45EA-86B5-6A5B54C12694

P304

Q34850830-0F6555AE-A8A5-49F7-9A1E-0C9CD1CEC052

P31

Q34850830-D2A66025-C923-48E6-B2F2-4B1B8EAE924D

P356

Q34850830-C4274289-1617-4B5E-9445-1E527288017B

P407

Q34850830-28913E82-061B-49B0-9DA7-BA4904FF45A9

P433

Q34850830-9B71D394-69AB-4EBD-AD58-9297BC489248

P478

Q34850830-4CFE2520-B858-4126-9152-DC85B21984E0

P577

Q34850830-08C8472F-03D9-41E2-93F4-2BE1C28FBF04

P5875

Q34850830-C52E75A3-BD96-4156-90DB-D9CCE5D67BCB

P698

Q34850830-7050BA70-B0B5-4C01-9B62-E38A0757CBDB

P932

Q34850830-1E02C756-44AA-4D53-A796-925F20543FE8

P356

JOURNAL.PONE.0068741

P1433

P1476

Characterization of vascular d ...... on with cognitive performance.

@en

P2093

Carey E Gleason

http://www.w3.org/2001/XMLSchema#string

Eliot A Brinton

http://www.w3.org/2001/XMLSchema#string

Frederick Naftolin

http://www.w3.org/2001/XMLSchema#string

Genevieve Neal-Perry

http://www.w3.org/2001/XMLSchema#string

George R Merriam

http://www.w3.org/2001/XMLSchema#string

Howard N Hodis

http://www.w3.org/2001/XMLSchema#string

Hugh Taylor

http://www.w3.org/2001/XMLSchema#string

Joann E Manson

http://www.w3.org/2001/XMLSchema#string

M Nanette Santoro

http://www.w3.org/2001/XMLSchema#string

Marcelle Cedars

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Women's Early Warning Symptoms of Acute Myocardial Infarction

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

Cognitive change and the APOE epsilon 4 allele

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

Risk factors for acute myocardial infarction in Copenhagen. I: Hereditary, educational and socioeconomic factors. Copenhagen City Heart Study

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

P304

e68741

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0068741

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

250926134

http://www.w3.org/2001/XMLSchema#string

P698

23874743

http://www.w3.org/2001/XMLSchema#string

P932

3714288

http://www.w3.org/2001/XMLSchema#string